BioSpace News Archive

Pharm Country

Lannett To Present At The 32nd annual Roth Conference On March 16

Lannett Company, Inc. announced that the company will present at the 32nd Annual ROTH Conference on March 16, 2020 at 2:30 p.m. PT at The Ritz Carlton, in Laguna Niguel, California.

March 9, 2020
·
1 min read
Business

Matinas BioPharma Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, reported financial results for the fourth quarter and full year ended December 31, 2019, along with a corporate update and outlook for 2020.

March 9, 2020
·
14 min read
Business

TransEnterix Schedules Fourth Quarter and Fiscal Year 2019 Financial and Operating Results Conference Call for March 16, 2020

TransEnterix, Inc. announced that it plans to release fourth quarter financial and Fiscal year 2019 operating results after the market closes on Monday, March 16, 2020.

March 9, 2020
·
1 min read
Pharm Country

Helius Medical Technologies, Inc. Provides Details on Five Recently Authorized PoNS Treatment™ Clinics Expands Access to PoNS Treatment™ in the Greater Toronto Area and Southwestern Ontario

Helius Medical Technologies, Inc., a neurotech company focused on neurological wellness, provided details on five additional PoNS Treatment™ clinics that were recently authorized in the Greater Toronto Area and Southwestern Ontario.

March 9, 2020
·
5 min read
BioMidwest

Coronavirus Impact on Blood Supply: Giving Blood Is Safe

Amidst novel coronavirus prevention measures, Vitalant and other blood centers nationwide are urging healthy individuals to donate blood—and organizations to maintain scheduled blood drives—to ensure patients have the lifesaving blood they need.

March 9, 2020
·
3 min read
Pharm Country

Bristol Myers Squibb Reports Primary Results of ELOQUENT-1 Study Evaluating Empliciti (elotuzumab) Plus Revlimid (lenalidomide) and Dexamethasone in Patients with Newly Diagnosed, Untreated Multiple Myeloma

Phase 3 trial did not meet primary endpoint of progression-free survival in patients not eligible for transplant

March 9, 2020
·
27 min read
Policy

AVROBIO Receives Orphan Drug Designation from U.S. FDA for AVR‑RD‑04 for Cystinosis

AVROBIO, Inc. announced that the U.S. Food and Drug Administration has granted orphan drug designation to the company’s investigational gene therapy, AVR-RD-04, for the treatment of cystinosis.

March 9, 2020
·
7 min read
Business

Bayer Partners with MassBio® to Launch Center for Regulatory Excellence to Support Startup Community

Center connects startups and academics to regulatory expertise; creates a forum for information sharing and networking

March 9, 2020
·
4 min read
Compugen Announces Updated Clinical Data from Ongoing COM701 Phase 1 Study

COM701 demonstrates preliminary antitumor activity with confirmed partial responses as monotherapy in a patient with primary peritoneal cancer and in combination with Opdivo® (Nivolumab) in a patient with MSS-CRC

March 9, 2020
·
7 min read
Biotech Beach

ImprimisRx® Announces Supply Agreement with iOR PartnersImprimisRx will supply iOR with a series of unique formulations needed during outpatient surgery

ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, and a wholly-owned subsidiary of Harrow Health, Inc. (NASDAQ: HROW), announced that it has agreed to a product supply agreement with iOR Partners.

March 9, 2020
·
5 min read